Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03655717 · ClinicalTrials.gov registry record · NA
Using Imaging to Assess Effects of THC on Brain Activity
A NA study of Intoxication Alcohol and Intoxication THC, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 316
- Enrollment target
- 1
- Study location
NCT03655717 is a NA study of Intoxication Alcohol and Intoxication THC that has completed, run by Massachusetts General Hospital. The registered enrollment target is 316 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03655717, a NA study of Intoxication Alcohol and Intoxication THC, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 316 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess effects of tetrahydrocannabinol (THC) and THC + alcohol in marijuana users on prefrontal brain activity, using functional near-infrared spectroscopy (fNIRS) during resting state and during memory task performance. Participants will complete fNIRS testing 120 minutes following THC or identical placebo (Phase 2A), or THC/ethanol, THC/placebo ethanol, placebo THC/ethanol, and placebo THC/placebo ethanol (Phase 2B), and oxygenated hemoglobin (HbO) concentration will be measured.
Conditions Studied
Interventions
- DRUG Ethanol
- DRUG Dronabinol
- DRUG Placebo dronabinol
- DRUG Placebo ethanol
Study Locations (1)
Massachusetts
- Center for Addiction Medicine, Massachusetts General Hospital, Dept. of Psychiatry - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 316 participants |
| Start Date | 2018-11-05 |
| Est. Completion | 2021-01-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03655717
The ClinicalTrials.gov registry entry for NCT03655717 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 316 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Intoxication Alcohol appearing as the primary indexed condition, and to 4 interventions - of which Ethanol is the first listed.
NCT03655717 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03655717 about?
NCT03655717 is a clinical study titled "Using Imaging to Assess Effects of THC on Brain Activity". This study will assess effects of tetrahydrocannabinol (THC) and THC + alcohol in marijuana users on prefrontal brain activity, using functional near-infrared spectroscopy (fNIRS) during resting state and during memory task performance. Participants will complete fNIRS testing 120 minutes following ...
What is the current status of trial NCT03655717?
This trial is currently completed. It is a NA study. The enrollment target is 316 participants. The study started on 2018-11-05. Estimated completion is 2021-01-21.
What conditions does trial NCT03655717 study?
This clinical trial studies the following conditions: Intoxication Alcohol, Intoxication THC, Intoxication Combined Alcohol THC.
What interventions are being tested in trial NCT03655717?
The interventions under investigation include: Ethanol (DRUG), Dronabinol (DRUG), Placebo dronabinol (DRUG), Placebo ethanol (DRUG).
Who is sponsoring clinical trial NCT03655717?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03655717 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.